Not Available

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$299,881.00
Award Year:
2010
Program:
SBIR
Phase:
Phase I
Contract:
N43CO201000095
Award Id:
96352
Agency Tracking Number:
N43CO201000095
Solicitation Year:
n/a
Solicitation Topic Code:
NCI
Solicitation Number:
n/a
Small Business Information
182 ELM ST, UNIT 3, CAMBRIDGE, MA, 02139-
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
Y
Duns:
829731814
Principal Investigator:
MAGDALENALESZCZYNIECKA
(617) 899-0724
mleszczyniecka@stcbiologics.com
Business Contact:
Research Institute:
n/a
Abstract

The goal of this project is to develop STC trastuzumab, a generic version of Herceptin. Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients with breast cancer. Because of very high cost associated with prescribing Herceptin, a generic version of this drug would make cancer treatment more affordable to a wider segment of the population and lower the cost burden on government-sponsored healthcare programs.  STC Biologics Inc. is uniquely positioned to address the technical challenge of reverse engineering trastuzumab as its drug development platform offers rapid and efficient analysis of post-translational modification of recombinant proteins.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government